Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

Jerusalem Pharmaceutical Company (JPH) earns a pretax income of JOD 1.31 million in the first half of 2010


Jerusalem Pharmaceutical (JPH) disclosed its semi- annual financial statements for the first half of 2010, and the company’s financial results as of 30/06/2010 indicated a pretax income of JOD 1.31 million comparing to JOD 0.57 million in the first half of 2009. The company’s assets reached JOD 26.41 m at the end 30/06/2010 after they reached 24.95 million  on 31/12/2009. Total liabilities reached JOD 5.18 million at the end of the first half of 2010 comparing to JOD 3.60 million as of 31/12/2009. Shareholders’ equity reached JOD 21.14 million  ( Excluding minority interest JOD 93,871) on 30/06/2010 after they reached JOD 21.24  million at the end of 2009( Excluding minority interest JOD 108,347) .


Al-Quds Index in the green zone despite the political instability



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013